Nureca Ltd.
Ticker > Company >

Nureca Ltd. share price

Nureca Ltd.

NSE: NURECA BSE: 543264 SECTOR: Medical Equipment/Supplies/Accessories  90k   298   22

280.00
-8.80 (-3.05%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 285

Today's Low

₹ 276.2

52 Week High

₹ 447

52 Week Low

₹ 198

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 280 Cr.

Enterprise Value

₹ 235.33 Cr.

No. of Shares

1 Cr.

P/E

0

P/B

1.45

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  192.48

CASH

₹ 46.2 Cr.

DEBT

₹ 1.52 Cr.

Promoter Holding

64.3 %

EPS (TTM)

₹  -0.67

Sales Growth

21.29%

ROE

-0.35 %

ROCE

0.34%

Profit Growth

72.65 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Nureca Ltd.

Dr. Trust Dr. Physio Trumom

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year21.29%
3 Year-23.45%
5 Year2.89%

Profit Growth

1 Year72.65%
3 Year-124.52%
5 Year-163.62%

ROE%

1 Year-0.35%
3 Year-1.94%
5 Year14.27%

ROCE %

1 Year0.34%
3 Year-2.12%
5 Year19%

Debt/Equity

0.0079

Price to Cash Flow

-15.1

Interest Cover Ratio

0.5874

CFO/PAT (5 Yr. Avg.)

0.341584589906738

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 64.30 0.00
Dec 2024 64.06 0.00
Sep 2024 63.77 0.00
Jun 2024 63.24 0.00
Mar 2024 63.24 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 77.3336 days.
  • Company has a healthy liquidity position with current ratio of 17.6592.
  • The company has a high promoter holding of 64.3%.

 Limitations

  • The company has shown a poor profit growth of -124.520575663308% for the Past 3 years.
  • The company has shown a poor revenue growth of -23.4482439415132% for the Past 3 years.
  • Company has a poor ROE of -1.9422% over the past 3 years.
  • Company has a poor ROCE of -2.12333333333333% over the past 3 years
  • Company has negative cash flow from operations of -18.548.
  • Tax rate is low at -45.2174.
  • The company has a low EBITDA margin of 3.23886% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 83.8062.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 19.56 23.31 32.37 27.21 31.75
Total Expenditure 24.32 26.23 35.03 31.94 31.18
Operating Profit -4.76 -2.91 -2.66 -4.73 0.57
Other Income -1.25 5.82 3.21 1.52 2
Interest 0.17 0.13 0.25 0.14 0.59
Depreciation 0.56 0.61 0.57 0.49 0.48
Exceptional Items 0 0 0 0 0
Profit Before Tax -6.74 2.16 -0.27 -3.85 1.5
Tax -2.33 0.97 0.38 -0.56 -0.57
Profit After Tax -4.41 1.2 -0.65 -3.29 2.07
Adjusted EPS (Rs) -4.41 1.2 -0.65 -3.29 2.07

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 213.33 255.55 111.9 94.52 114.64
Total Expenditure 151.65 199.78 127.29 105.67 124.64
Operating Profit 61.68 55.77 -15.39 -11.15 -10
Other Income 2.82 7.72 7.17 10.58 12.81
Interest 1.6 0.73 0.43 0.46 1.12
Depreciation 0.41 1.43 2.3 2.24 2.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 62.49 61.33 -10.96 -3.27 -0.46
Tax 15.96 16.02 -2.54 -0.83 0.21
Net Profit 46.53 45.31 -8.42 -2.44 -0.67
Adjusted EPS (Rs.) 46.53 45.31 -8.42 -2.44 -0.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 10 10 10 10 10
Total Reserves 153.29 193.74 185.26 182.86 182.48
Borrowings 0.78 0 0 0.33 1.05
Other N/C liabilities 2.46 3.59 0.11 -2.5 -1.06
Current liabilities 33.88 45.14 8.62 9.27 10.44
Total Liabilities 200.41 252.48 203.98 199.96 202.91
Assets
Net Block 3.37 9.78 8.08 6.33 7.8
Capital WIP 0 0 0 0 0
Intangible WIP 0.3 0.42 0 0 0
Investments 0.82 1.31 3.06 3.06 3.06
Loans & Advances 0.09 0.26 1.61 0.92 3.86
Other N/C Assets 0 1.95 7.24 0 3.82
Current Assets 195.84 238.76 184 189.66 184.38
Total Assets 200.41 252.48 203.98 199.96 202.91
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 62.49 61.33 -10.96 -3.27 -0.46
Adjustment 0.09 -3.79 -3.64 -6.98 -8.2
Changes in Assets & Liabilities -12.42 -37.76 30.78 5.76 -8.86
Tax Paid -15.07 -17.96 -4.14 1.49 -1.03
Operating Cash Flow 35.1 1.83 12.05 -3 -18.55
Investing Cash Flow -110.48 -3.37 -18.3 17.84 8.56
Financing Cash Flow 92.34 -7.3 -1.51 -1.28 -0.79
Net Cash Flow 16.96 -8.84 -7.76 13.56 -10.77

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 63.24 63.24 63.77 64.06 64.30
aryan goyal - - 3.63 - 7.23
nectar biopharma private ... - - 0.54 0.61 0.61
payal goyal - - 27.98 - 24.60
saurabh goyal - - 31.62 - 31.86
aryan goyal 3.76 3.76 - 3.68 -
payal goyal 27.98 27.98 - 28.10 -
saurabh goyal 31.49 31.49 - 31.67 -
PARTICULARS Jun 2022% Sep 2022% Sep 2024% Dec 2024% Mar 2025%
investors 30.00 30.00 36.23 35.94 35.70
nisarg vakharia - - - - 1.78
llp - - 0.02 0.02 -
hornbill orchid india fun... 3.89 1.44 - - -
nexpact limited 7.32 - - - -
next orbit ventures fund 3.88 - - - -
quant mutual fund - quant... 1.35 - - - -
yash shares and stock pri... 3.41 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Presentation Q4FY25
Presentation Q4FY24
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY22

Company News

 No Latest News available for this company.
Report us

Nureca Ltd. Stock Price Analysis and Quick Research Report. Is Nureca Ltd. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Nureca Ltd. stock price today is Rs 279.65. So, let’s look into Nureca Ltd. and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -18.548 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Nureca Ltd. has a Debt to Equity ratio of 0.0079 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Nureca Ltd. , the EPS growth was 72.6454 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Nureca Ltd. has OPM of -8.72470341939986 % which is a bad sign for profitability.
     
  • ROE: Nureca Ltd. have a poor ROE of -0.3467 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Nureca Ltd. is Rs 279.65. One can use valuation calculators of ticker to know if Nureca Ltd. share price is undervalued or overvalued.
Last Updated on:
Brief about Nureca Ltd.
X